Frontiers in pediatrics · 2025
Expression and clinical significance of Klotho protein in serum, umbilical cord blood, and placenta of pregnant women with intrauterine growth restriction.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zeng Guixiang, Lian Jingjing, Shen Jiajia, Shi Yuan
Аннотация
OBJECTIVES: Intrauterine growth restriction (IUGR) significantly affects neonatal development, but its pathogenesis is not fully understood. Klotho protein is involved in aging-related diseases, and its role in fetal growth is unclear. This study aims to explore Klotho's role in IUGR.
METHODS: A case-control study was conducted at Nanning Maternal and Child Health Care Hospital from July 2023 to June 2024. Fifty-two neonates (gestational age ≥34 weeks and <42 weeks) were divided into the appropriate for gestational age (AGA) group (n = 30) and the IUGR group (n = 22). Venous and umbilical cord blood were collected to measure Klotho, growth hormone (GH), and insulin-like growth factor 1 (IGF-1). Placental tissues were examined for histopathology and immunohistochemistry.
RESULTS: The IUGR group showed placental morphological changes, including increased syncytial knots and inflammation. Klotho expression in placental tissue was significantly reduced (p < 0.0001), while IGF-1 levels increased (p < 0.001) and GH levels decreased (p < 0.001). Soluble α-Klotho levels were lower in maternal venous blood (p < 0.0001) and umbilical cord blood (p < 0.01). GH and IGF-1 levels in maternal venous blood and umbilical cord blood were altered in IUGR cases.
CONCLUSIONS: Reduced Klotho expression in IUGR cases, along with changes in GH and IGF-1, suggests disruptions in metabolic processes affecting fetal growth and development. These findings suggest a potential involvement of Klotho in placental changes and fetal development, warranting further mechanistic studies.
METHODS: A case-control study was conducted at Nanning Maternal and Child Health Care Hospital from July 2023 to June 2024. Fifty-two neonates (gestational age ≥34 weeks and <42 weeks) were divided into the appropriate for gestational age (AGA) group (n = 30) and the IUGR group (n = 22). Venous and umbilical cord blood were collected to measure Klotho, growth hormone (GH), and insulin-like growth factor 1 (IGF-1). Placental tissues were examined for histopathology and immunohistochemistry.
RESULTS: The IUGR group showed placental morphological changes, including increased syncytial knots and inflammation. Klotho expression in placental tissue was significantly reduced (p < 0.0001), while IGF-1 levels increased (p < 0.001) and GH levels decreased (p < 0.001). Soluble α-Klotho levels were lower in maternal venous blood (p < 0.0001) and umbilical cord blood (p < 0.01). GH and IGF-1 levels in maternal venous blood and umbilical cord blood were altered in IUGR cases.
CONCLUSIONS: Reduced Klotho expression in IUGR cases, along with changes in GH and IGF-1, suggests disruptions in metabolic processes affecting fetal growth and development. These findings suggest a potential involvement of Klotho in placental changes and fetal development, warranting further mechanistic studies.